Associations of Exhaled Carbon Monoxide and Fractional Exhaled Nitric Oxide with Metabolic Syndrome: A Cohort Study

[1]  J. Fassett,et al.  Effect of asymmetric dimethylarginine (ADMA) on heart failure development. , 2016, Nitric oxide : biology and chemistry.

[2]  Lin-fang Wang,et al.  Anti-oxidant effect of heme oxygenase-1 on cigarette smoke-induced vascular injury , 2015, Molecular medicine reports.

[3]  Tanshi Li,et al.  Fractional Exhaled Nitric Oxide in Healthy Tibetans at High Altitude , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[4]  Danielle M. Enserro,et al.  Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes. , 2014, European heart journal.

[5]  Tangchun Wu,et al.  The Wuhan-Zhuhai (WHZH) cohort study of environmental air particulate matter and the pathogenesis of cardiopulmonary diseases: study design, methods and baseline characteristics of the cohort , 2014, BMC Public Health.

[6]  M. Schivo,et al.  Diabetes and the Metabolic Syndrome: Possibilities of a New Breath Test in a Dolphin Model , 2013, Front. Endocrinol..

[7]  L. Avigliano,et al.  Obesity-Associated Oxidative Stress: Strategies Finalized to Improve Redox State , 2013, International journal of molecular sciences.

[8]  F. Holguin.  Arginine and Nitric Oxide Pathways in Obesity-Associated Asthma , 2013, Journal of allergy.

[9]  S. Ryter,et al.  Carbon monoxide in exhaled breath testing and therapeutics , 2013, Journal of breath research.

[10]  K. Bønnelykke,et al.  Fraction of exhaled nitric oxide and bronchial responsiveness are associated and continuous traits in young children independent of asthma. , 2012, Chest.

[11]  Jason S. Yip,et al.  Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis , 2012, Allergy and asthma proceedings.

[12]  K. Groundstroem,et al.  Exhaled nitric oxide and atherosclerosis , 2012, European journal of clinical investigation.

[13]  D. Blake,et al.  The clinical potential of exhaled breath analysis for diabetes mellitus. , 2012, Diabetes research and clinical practice.

[14]  R. Dweik,et al.  Cardiovascular biomarkers in exhaled breath. , 2012, Progress in cardiovascular diseases.

[15]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[16]  Margaret W Leigh,et al.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. , 2011, American journal of respiratory and critical care medicine.

[17]  D. Ryu,et al.  The role of carbon monoxide in metabolic disease , 2011, Annals of the New York Academy of Sciences.

[18]  R. Vasan,et al.  Exhaled Carbon Monoxide and Risk of Metabolic Syndrome and Cardiovascular Disease in the Community , 2010, Circulation.

[19]  François Mariotti,et al.  Dose‐response analyses using restricted cubic spline functions in public health research , 2010, Statistics in medicine.

[20]  M. Maniscalco,et al.  Exhaled nitric oxide and other major exhaled compounds for the diagnosis of metabolic diseases. , 2009, Expert opinion on medical diagnostics.

[21]  B. Pannen,et al.  Bench-to-bedside review: Carbon monoxide – from mitochondrial poisoning to therapeutic use , 2009, Critical care.

[22]  R. Dweik,et al.  Exhaled breath analysis: the new frontier in medical testing , 2008, Journal of breath research.

[23]  W. Aronow,et al.  Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance , 2008, Diabetes.

[24]  A. Agarwal,et al.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. , 2008, Circulation.

[25]  Bogusław Buszewski,et al.  Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.

[26]  Z. Puthucheary,et al.  Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy Environment , 2006, Mediators of inflammation.

[27]  Jawed Alam,et al.  Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. , 2006, Physiological reviews.

[28]  A Y M Jones,et al.  End-expiratory carbon monoxide levels in healthy subjects living in a densely populated urban environment. , 2006, The Science of the total environment.

[29]  Lingyun Wu,et al.  Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications , 2005, Pharmacological Reviews.

[30]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[31]  S. Ryter,et al.  Carbon Monoxide: To Boldly Go Where NO Has Gone Before , 2004, Science's STKE.

[32]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[33]  P. Hormbrey,et al.  Breath analysis to detect recent exposure to carbon monoxide , 2002, Postgraduate medical journal.

[34]  E. Vicaut,et al.  Role of nitric oxide and cyclooxygenase pathways in the coronary vascular effects of halothane, isoflurane and desflurane in red blood cell-perfused isolated rabbit hearts. , 2002, British journal of anaesthesia.

[35]  P. Montuschi,et al.  Exhaled carbon monoxide and nitric oxide in COPD. , 2001, Chest.

[36]  P. Barnes,et al.  Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke , 2001, Thorax.

[37]  K. Utsumi,et al.  Interrelation between oxygen tension and nitric oxide in the respiratory system. , 2000, American Journal of Respiratory and Critical Care Medicine.

[38]  P. Barnes,et al.  Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? , 1999, Chest.

[39]  A. Arroliga,et al.  Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.

[40]  C. T. Wagner,et al.  Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. , 1997, The Journal of clinical investigation.

[41]  E. Kandel,et al.  Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. , 1993, Science.

[42]  Jason S. Yip,et al.  Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis , 2012 .

[43]  T. Ahmad,et al.  Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs. , 2010, American journal of respiratory cell and molecular biology.